In a recent press release, CareSignal announced an expansion of its Deviceless Remote Patient Monitoring (RPM) offering, bringing clinically validated, scalable solutions for remote monitoring to organizations providing – or planning to provide – virtual patient care.
In collaboration with Deloitte, Deloitte clients throughout the health care sector are able to deploy CareSignal’s Deviceless RPM – an accessible, condition-specific monitoring and engagement solution that delivers improved clinical visibility and strong financial returns for all value-based populations.
The COVID-19 pandemic, along with subsequent operational shifts, have forced health care delivery away from analog and toward digital. CareSignal Deviceless RPM, with 12 peer-reviewed journal publications, provides care teams with the real-time data necessary to sustain clinically impactful relationships, especially those working with chronic and behavioral health conditions.
Jay Compton, managing director, Deloitte Consulting LLP, and chief technology officer, ConvergeHEALTH by Deloitte, emphasizes the timeliness of scalable, clinically actionable remote monitoring: “This offering combines the best of traditional remote patient monitoring and large-scale patient engagement. By leveraging universally available technology, ranging from landline phone calls and text messages to smartphone apps, prior barriers to successful long-term monitoring are eliminated with this offering.”
The Deloitte-CareSignal collaboration is the result of extensive diligence and detailed market analysis. “The deep clinical evidence and demonstrated real-world financial impact of CareSignal are compelling,” said Bill Fera, M.D., principal, Deloitte Consulting LLP. “As the early majority adopt value-based, patient-centered models of care, a strong, operationally viable technology strategy must include not only population health and virtual care delivery, but also the type of longitudinal remote monitoring CareSignal and Deloitte now provide.”
“CareSignal is excited to have the opportunity to serve Deloitte and the organization’s industry-leading health care clients nationally,” said Blake Marggraff, CEO and founder of CareSignal. “The fundamental priority for our company is long-term, clinically actionable engagement for the most challenging populations, including those with health literacy and technological limitations. Together, I am confident that CareSignal and Deloitte will positively impact both the patients and the organizations that have the most to gain during the continued transition to digital-first care.”
ABOUT DELOITTE:
Please see www.deloitte.com/us/about for a detailed description of our legal structure.
ABOUT CARESIGNAL:
CareSignal is Deviceless Remote Patient Monitoring® for value-based care. The company leverages real-time, self-reported patient data and artificial intelligence to produce long-term patient engagement while identifying clinically actionable moments for proactive care delivery. Proven in 12 peer-reviewed studies and over a dozen payer and provider implementations to sustainably scale care teams to help 10 times more patients, resulting in significant improvements in chronic and behavioral health outcomes and reduced ED utilization. Learn more: visit our website or try a self-guided demo.